Table showing baseline characteristics of the participants enrolled in the trial and the p value between the drug and placebo groups to show presence of statistical significance
| Variable | Racecadotril n (%) | Placebo n (%) | p Value* |
|---|---|---|---|
| Sex: male | 27 (45) | 38 (63) | |
| Female | 33 (55) | 22 (37) | 0.04† |
| Malnutrition | |||
| None | 34 (57) | 28 (47) | 0.27 |
| Mild to moderate | 17 (28) | 16 (27) | |
| Severe | 09 (15) | 16 (27) | |
| Duration of diarrhoea‡ (days) | |||
| ≤4 | 31 (51) | 32 (53) | 0.97 |
| 5 | 15 (23) | 14 (23) | |
| ≥6 | 14 (23) | 14 (23) | |
| Dehydration | |||
| No | 3 (5) | 4(6) | 0.43 |
| Some | 26 (43) | 32 (53) | |
| Severe | 31 (51) | 24 (40) | |
*Pearson constant on χ2 test.
†Significant difference in sex ratio between the placebo and drug groups, suspected to be due to chance.
‡Duration of diarrhoea given as the number of patients (and %) who fell into each of the three groups as given by the Vesikari score.